Search company, investor...
Stelexis Therapeutics company logo

Stelexis Therapeutics

stelexis.com

Founded Year

2017

Stage

Series A | Alive

Total Raised

$43M

Last Raised

$43M | 5 yrs ago

About Stelexis Therapeutics

Stelexis is a cancer therapeutics company, utilizing its proprietary platform to selectively target pre-cancerous stem cells to discover and develop therapies. Its proprietary drug discovery platform identifies the earliest definable pre-cancerous stem and progenitor cells that lead to the formation of human primary and recurrent tumors for therapeutic intervention and relapse prevention.

Headquarters Location

780 Third Avenue

New York, New York, 10017,

United States

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Latest Stelexis Therapeutics News

Venture roundup: Apic, Stelexis, Biond, Keros

Jan 14, 2019

Venture roundup: Apic, Stelexis, Biond, Keros 9:41 AM PDF Gene therapy company Apic Bio Inc. (Cambridge, Mass.) and cancer company Stelexis Therapeutics LLC (New York, N.Y.) each announced series A rounds of at least $40 million. Other companies that announced venture rounds include Biond Biologics Ltd. (Misgav Industrial Park, Israel), which raised $17 million in a series B round, and Keros Therapeutics Inc. (Lexington, Mass. ), which raised a $23 million series B round. Apic plans to use its $40 million series A to develop APB-101, a "liver sparing" gene therapy treatment... Read the full 387 word article User Sign in

Stelexis Therapeutics Frequently Asked Questions (FAQ)

  • When was Stelexis Therapeutics founded?

    Stelexis Therapeutics was founded in 2017.

  • Where is Stelexis Therapeutics's headquarters?

    Stelexis Therapeutics's headquarters is located at 780 Third Avenue, New York.

  • What is Stelexis Therapeutics's latest funding round?

    Stelexis Therapeutics's latest funding round is Series A.

  • How much did Stelexis Therapeutics raise?

    Stelexis Therapeutics raised a total of $43M.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.